Latest news
Loading news…
KalVista Pharmaceuticals
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 MediumHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Cambridge, Massachusetts, United States Founded 2011 251-500 employees For Profit
KalVista Pharmaceuticals focuses on developing oral medicines, particularly for managing hereditary angioedema.
KalVista Pharmaceuticals on Acquirezy — acquisitions, funding rounds, investments, investors, key people & contacts.
KalVista Pharmaceuticals was acquired by Chiesi Farmaceutici in 2026 for $1.9B.
Total Funding
$703.8M
Funding Rounds
6
Last Funding
Acquisitions
1
Monthly Visits
Contacts
119
Ticker
KALV
NASDAQ
About KalVista Pharmaceuticals
Funding & Financials
- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Public
- Ticker
- KALV
- Exchange
- NASDAQ
- IPO date
- Nov 22, 2016
- Raised at IPO
- $68M
Web Traffic
- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 28
- Active products
- 20
- IT spend
- $30.94K
Company Info
- Founded
- 2011
- Employees
- 251-500
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 4
- News articles
- 382
- HQ
- Cambridge, Massachusetts, United States
- Region
- Greater Boston Area, East Coast, New England
- Exit date
- Nov 22, 2016
Signals & Scores
- Heat score
- Medium
- Growth score
- Low
- Trend (7d)
- -0.2
- Trend (30d)
- -2.9
- Trend (90d)
- 3
- Last leadership hire
- Nov 10, 2025
KalVista Pharmaceuticals Funding Rounds
6 results
Upgrade to Pro to view this datasetUpgrade
| Organization Name | Funding Type | Lead Investor Names | Investor Names | Funding Stage | Org Industries | Org Hq City | Org Hq Country | Org Description | Org Number Of Employees | Org Website | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1–5 of 6Show
Page 1 / 2
KalVista Pharmaceuticals Acquisitions
1 results
| Acquiree Name | Acquirer Name | Acquisition Type | Acquisition Terms | Acquiree Industries | Acquiree Hq City | Acquiree Hq Country | Acquiree Description | Acquiree Number Of Employees | Acquirer Industries | Acquirer Hq Country | Acquirer Number Of Employees | Acquirer Ipo Status | Acquiree Website | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Carbylan Therapeutics | — | 2016-06-15 | KalVista Pharmaceuticals | Acquisition | — | Health CareHealth DiagnosticsTherapeutics | Palo Alto | United States | Carbylan Therapeutics was founded in 2004 | 2005-01-01 | 11-50 | BiopharmaBiotechnologyDiabetesHealth CarePharmaceutical | United States | 251-500 | Public | 1 | www.carbylan.com |
1–1 of 1Show
Page 1 / 1
KalVista Pharmaceuticals Key People
Founder & CEO
Chief Development Officer
CFO
Chief Executive Officer
CPO
COO
Co-Founder
Chief Commercial Officer
Co-Founder
119
professional contacts at KalVista Pharmaceuticals
Contact execs at KalVista Pharmaceuticals →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Bulk Dataset Export
Need the data in bulk? Buy the entire dataset.
5.4M company profiles200K+ acquisitions700K+ funding rounds327K investors2M+ people61M contacts45K schools
Delivered as CSV, JSON or Parquet — at startup-friendly pricing.
FAQs about KalVista Pharmaceuticals
People who checked this page also checked these
Sectors KalVista Pharmaceuticals invests & acquires in
Browse the full Acquirezy directory.